PriceTracker GLP-1

GLP-1 TV · Patient story · views checked Oct 2026

Diabetes Dialogue: Orforglipron, Retatrutide, and Other GLP-1 Updates

Patient storyHCPLive559 views26:42Mar 2026

Our summary

A patient shares their experience with Foundayo, mentioning 9 mg. Side effects mentioned: nausea, constipation and diarrhea. Also covers cost and insurance and the trials.

One person's experience, in their words. Not medical advice.

Key moments

From the creator's own chapters. Tap one to play from there.

  1. 0:00 <Untitled Chapter 1>
  2. 0:01 Intro
  3. 0:22 Orforglipron in the ACHIEVE-3 trial
  4. 3:30 Side effects from orforglipron
  5. 10:28 Retatrutide in the TRIUMPH-4 trial
  6. 18:26 Topline data on Novo Nordisk's UBT251
  7. 21:47 Price cuts on Ozempic, Rybelsus, and Wegovy in 2027
  8. 26:26 Outro

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Foundayo and retatrutide
Doses mentioned
9 mg
Side effects mentioned
nausea, constipation and diarrhea
Who is speaking
Patient

Find more like it

Side effectsDose changeWeigh-in and resultsCost and insuranceThe trialsNauseaConstipationDiarrhea

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV